WEBVTT

1
00:00:00.080 --> 00:00:02.319
- Hello, everyone. This is Jacob Emerson with the

2
00:00:02.319 --> 00:00:04.099
- Becker's Payer Issues podcast.

3
00:00:04.480 --> 00:00:06.399
- I'm thrilled today to be joined by Haley

4
00:00:06.399 --> 00:00:09.039
- Park, who serves as senior vice president and

5
00:00:09.039 --> 00:00:11.939
- chief pharmacy officer at Blue Shield of California.

6
00:00:12.474 --> 00:00:14.314
- Haley, thank you very much for taking the

7
00:00:14.314 --> 00:00:15.754
- time to be with me on the podcast

8
00:00:15.754 --> 00:00:16.254
- today.

9
00:00:16.634 --> 00:00:18.795
- Hi, Jacob. Thank you for having me. It's

10
00:00:18.795 --> 00:00:21.355
- a pleasure to be here. Absolutely. And thanks

11
00:00:21.355 --> 00:00:23.134
- for taking the time to chat with us.

12
00:00:23.594 --> 00:00:25.515
- Before we get started, Haley, I know you're

13
00:00:25.515 --> 00:00:27.035
- new to your role and so... Or this

14
00:00:27.035 --> 00:00:28.289
- year at least. And so,

15
00:00:28.769 --> 00:00:30.530
- for our audience who might not be familiar

16
00:00:30.530 --> 00:00:32.609
- with you, I'm hoping you could tell them

17
00:00:32.609 --> 00:00:35.090
- a little bit more about yourself, your background

18
00:00:35.090 --> 00:00:36.850
- in health care, and what it is that

19
00:00:36.850 --> 00:00:38.710
- you do today at Blue Shield of California.

20
00:00:39.570 --> 00:00:40.710
- Yeah. Thanks, Jacob.

21
00:00:41.664 --> 00:00:43.424
- So as you mentioned, I've been here for

22
00:00:43.424 --> 00:00:46.064
- about six months and super excited to have

23
00:00:46.064 --> 00:00:48.704
- joined the Blue Shield of California team. I'm

24
00:00:48.704 --> 00:00:52.064
- a pharmacist by training, and, I spent more

25
00:00:52.064 --> 00:00:54.725
- than twenty five years across retail pharmacy,

26
00:00:55.649 --> 00:00:58.929
- disease management, integrated health systems, and now, with

27
00:00:58.929 --> 00:00:59.909
- the health plan.

28
00:01:00.929 --> 00:01:02.929
- And what's been really interesting is I've seen

29
00:01:02.929 --> 00:01:06.290
- what happens when we optimize for individual parts

30
00:01:06.290 --> 00:01:07.670
- of the health care system

31
00:01:08.305 --> 00:01:10.864
- and then what's possible when you start to

32
00:01:10.864 --> 00:01:12.164
- connect them all together.

33
00:01:13.104 --> 00:01:14.644
- The other really interesting

34
00:01:15.024 --> 00:01:17.284
- observation I've had is that the incentives

35
00:01:17.664 --> 00:01:20.545
- are very different depending on which seat at

36
00:01:20.545 --> 00:01:22.084
- the table you're at.

37
00:01:22.989 --> 00:01:25.730
- I've seen at retail how it's about prescription

38
00:01:25.790 --> 00:01:26.290
- volume

39
00:01:26.750 --> 00:01:27.489
- in hospitals,

40
00:01:28.270 --> 00:01:31.170
- rigorous medication oversight and a focus on turnover.

41
00:01:31.790 --> 00:01:32.590
- And of course,

42
00:01:33.150 --> 00:01:35.629
- you know, our focus around PBMs at Blue

43
00:01:35.629 --> 00:01:37.504
- Shield of California and how they have some

44
00:01:37.504 --> 00:01:40.245
- very sophisticated tools to manage drug spending,

45
00:01:40.784 --> 00:01:44.224
- but often with incentives that don't necessarily align

46
00:01:44.224 --> 00:01:45.045
- with patients.

47
00:01:45.745 --> 00:01:47.424
- And that's really what drew me to Blue

48
00:01:47.424 --> 00:01:49.745
- Shield of California. As a not for profit

49
00:01:49.745 --> 00:01:50.564
- health plan,

50
00:01:50.990 --> 00:01:52.370
- we have the opportunity

51
00:01:52.829 --> 00:01:53.490
- to bring,

52
00:01:53.870 --> 00:01:55.969
- like, benefits of an integrated

53
00:01:56.430 --> 00:02:00.030
- care system to a much broader population and

54
00:02:00.030 --> 00:02:01.010
- not through ownership,

55
00:02:01.469 --> 00:02:02.450
- but through partnerships.

56
00:02:03.725 --> 00:02:06.145
- Because the real measure, I think, of integration,

57
00:02:06.525 --> 00:02:08.444
- it's not how much of the system you

58
00:02:08.444 --> 00:02:11.425
- own, but how well the system actually works

59
00:02:11.564 --> 00:02:13.805
- together for the people that... And the members

60
00:02:13.805 --> 00:02:14.625
- that we serve.

61
00:02:15.639 --> 00:02:17.719
- Absolutely. And and let me follow-up with what

62
00:02:17.719 --> 00:02:19.719
- you just said there, Haley, in terms of,

63
00:02:19.960 --> 00:02:20.620
- the incentives

64
00:02:21.000 --> 00:02:23.340
- look different across the different types of organizations

65
00:02:23.800 --> 00:02:25.879
- that you're at in health care. And, you

66
00:02:25.879 --> 00:02:28.200
- know, we've been speaking with Blue Shield leaders

67
00:02:28.200 --> 00:02:28.919
- for years,

68
00:02:29.240 --> 00:02:31.455
- or last few years of about,

69
00:02:32.155 --> 00:02:34.495
- a a pharmacy model that was launched,

70
00:02:34.794 --> 00:02:37.114
- a few years back to shift how prescription

71
00:02:37.114 --> 00:02:39.534
- drugs have traditionally been priced and delivered

72
00:02:39.995 --> 00:02:41.694
- within the industry. And so

73
00:02:42.474 --> 00:02:43.849
- maybe we could back up for a for

74
00:02:43.849 --> 00:02:45.770
- a second and have you tell our audience

75
00:02:45.770 --> 00:02:48.110
- who who isn't familiar with the the model,

76
00:02:48.730 --> 00:02:50.349
- the the basics of this approach

77
00:02:50.650 --> 00:02:53.069
- and and the results that you've seen,

78
00:02:53.530 --> 00:02:55.150
- since its since its launch.

79
00:02:56.185 --> 00:02:56.925
- Yeah. Absolutely.

80
00:02:57.705 --> 00:02:57.944
- And,

81
00:02:58.665 --> 00:03:00.844
- within our pharmacy care reimagined

82
00:03:01.385 --> 00:03:01.885
- initiatives,

83
00:03:02.824 --> 00:03:05.645
- what we've done is taken the traditional pharmacy

84
00:03:05.705 --> 00:03:08.525
- benefit management model, which is typically

85
00:03:09.064 --> 00:03:09.564
- integrated.

86
00:03:10.319 --> 00:03:11.620
- So lots of different,

87
00:03:12.159 --> 00:03:12.659
- functionalities

88
00:03:13.120 --> 00:03:14.580
- are done by one company.

89
00:03:15.199 --> 00:03:18.259
- And, unfortunately, that is incredibly opaque.

90
00:03:19.199 --> 00:03:21.699
- And as a health plan, you have surprisingly

91
00:03:22.159 --> 00:03:24.500
- very little control over the economics.

92
00:03:25.414 --> 00:03:27.675
- So what we did through pharmacy care reimagined

93
00:03:27.735 --> 00:03:30.074
- is we changed the economics of pharmacy,

94
00:03:30.694 --> 00:03:32.775
- not just change who manages it. So there

95
00:03:32.775 --> 00:03:34.775
- was a lot of thought that went into

96
00:03:34.775 --> 00:03:35.174
- this.

97
00:03:35.574 --> 00:03:37.735
- One example that I'll bring up is the

98
00:03:37.735 --> 00:03:38.955
- Humira biosimilar,

99
00:03:39.960 --> 00:03:41.180
- And the biosimilars

100
00:03:41.639 --> 00:03:42.699
- are, of course,

101
00:03:43.000 --> 00:03:45.979
- much lower priced than their brand.

102
00:03:46.759 --> 00:03:49.580
- And so when it became available, you would

103
00:03:49.879 --> 00:03:52.360
- naturally believe that there would be,

104
00:03:52.759 --> 00:03:54.919
- a very quick adoption to get to this

105
00:03:54.919 --> 00:03:58.625
- lower priced medication that was essentially clinically, you

106
00:03:58.625 --> 00:03:59.525
- know, similar

107
00:04:00.064 --> 00:04:02.784
- to, their brand. But what we saw was

108
00:04:02.784 --> 00:04:06.965
- adoption was really slow because preferring this biosimilar

109
00:04:07.344 --> 00:04:08.085
- could put,

110
00:04:08.930 --> 00:04:12.549
- a significant portion of branded rebates at risk.

111
00:04:13.330 --> 00:04:15.669
- So you had to balance the economics.

112
00:04:16.689 --> 00:04:18.610
- So when you think about it, you finally

113
00:04:18.610 --> 00:04:19.430
- have competition,

114
00:04:20.050 --> 00:04:22.610
- but the rebate system could penalize us for

115
00:04:22.610 --> 00:04:23.350
- using it.

116
00:04:23.835 --> 00:04:26.175
- So when we announced our pharmacy care reimagine

117
00:04:26.314 --> 00:04:29.134
- model, it was a modular system in '23.

118
00:04:29.435 --> 00:04:31.375
- We launched it in '25.

119
00:04:31.995 --> 00:04:34.895
- And, what's great is that it's building upon

120
00:04:34.955 --> 00:04:37.595
- existing innovative partnerships that had been in place

121
00:04:37.595 --> 00:04:38.895
- for nearly a decade.

122
00:04:39.699 --> 00:04:41.779
- The early results you had asked for, well,

123
00:04:41.779 --> 00:04:44.599
- today we're sitting at about an 85%

124
00:04:44.819 --> 00:04:45.319
- biosimilar

125
00:04:45.620 --> 00:04:46.599
- adoption rate,

126
00:04:46.899 --> 00:04:49.459
- and we were able to negotiate what began

127
00:04:49.459 --> 00:04:51.220
- at about $500

128
00:04:51.220 --> 00:04:52.665
- in terms of a net price

129
00:04:53.145 --> 00:04:55.625
- compared to a list price for Humira of

130
00:04:55.625 --> 00:04:56.745
- $7,000,

131
00:04:56.745 --> 00:04:58.205
- so a significant reduction.

132
00:04:59.064 --> 00:05:02.205
- Another example is our partnership through Civica Script.

133
00:05:02.745 --> 00:05:04.845
- And here we targeted generic,

134
00:05:05.944 --> 00:05:06.444
- specialty

135
00:05:07.064 --> 00:05:07.564
- medications.

136
00:05:08.209 --> 00:05:10.129
- And this is not typically a place where

137
00:05:10.129 --> 00:05:11.110
- rebates play.

138
00:05:11.569 --> 00:05:13.410
- But what we were able to see through

139
00:05:13.410 --> 00:05:16.689
- the partnership with Civica is a 41%

140
00:05:16.689 --> 00:05:18.069
- reduction in abiraterone,

141
00:05:18.449 --> 00:05:20.550
- which is a prostate cancer medication,

142
00:05:21.324 --> 00:05:22.845
- and a 64%

143
00:05:22.845 --> 00:05:24.064
- reduction for capsidabine,

144
00:05:24.365 --> 00:05:25.585
- which is an oral chemotherapy,

145
00:05:26.845 --> 00:05:27.345
- drug.

146
00:05:27.964 --> 00:05:30.524
- And, of course, we wanna lower the spend

147
00:05:30.524 --> 00:05:33.884
- because that's ultimately gonna lower premiums for employers

148
00:05:33.884 --> 00:05:34.545
- and members.

149
00:05:35.160 --> 00:05:37.080
- But another thing that I really think about

150
00:05:37.080 --> 00:05:39.960
- is that upfront discount that lowers the member's

151
00:05:39.960 --> 00:05:41.980
- cost share at the pharmacy counter.

152
00:05:42.439 --> 00:05:44.520
- And so we're not just lowering drug costs,

153
00:05:44.520 --> 00:05:47.639
- we're also changing who benefits from the savings

154
00:05:47.639 --> 00:05:49.884
- and when those benefits occur. And that was

155
00:05:49.884 --> 00:05:52.524
- really important to me. And that's really some

156
00:05:52.524 --> 00:05:55.004
- amazing numbers you just cited there, Haley, especially

157
00:05:55.004 --> 00:05:57.644
- around the Humira and and, getting that cost

158
00:05:57.644 --> 00:06:00.544
- down to 7,000 plus price down to 500.

159
00:06:01.164 --> 00:06:02.865
- I wonder, you know, when we talk to

160
00:06:04.449 --> 00:06:07.089
- pharmacy health plan leaders from from around the

161
00:06:07.089 --> 00:06:07.589
- country,

162
00:06:08.050 --> 00:06:09.829
- right now we've been hearing from them

163
00:06:10.290 --> 00:06:12.930
- in talking about the pipeline of specialty medications

164
00:06:12.930 --> 00:06:13.589
- and therapies,

165
00:06:14.129 --> 00:06:16.529
- especially as the years go on and and

166
00:06:16.529 --> 00:06:18.550
- trying to evolve their their benefits

167
00:06:18.930 --> 00:06:21.365
- and, trying to keep those medications,

168
00:06:22.144 --> 00:06:23.444
- accessible and affordable.

169
00:06:23.745 --> 00:06:25.584
- And so I wonder going off of what

170
00:06:25.584 --> 00:06:27.104
- you just... You laid out for us and

171
00:06:27.104 --> 00:06:28.944
- and, like I said, what we're hearing from

172
00:06:28.944 --> 00:06:31.104
- across the industry, what do you see in

173
00:06:31.104 --> 00:06:33.810
- some of the biggest trends shaping the pharmacy

174
00:06:33.810 --> 00:06:35.410
- industry right now, and and how does that

175
00:06:35.410 --> 00:06:35.910
- all,

176
00:06:36.370 --> 00:06:38.129
- play into what you all are trying to

177
00:06:38.129 --> 00:06:40.229
- do with Blue Shield of of keeping things

178
00:06:40.290 --> 00:06:41.910
- accessible and affordable,

179
00:06:42.769 --> 00:06:44.709
- under an evolving benefits model?

180
00:06:45.415 --> 00:06:48.055
- Yeah. Jacob, there are so many forces right

181
00:06:48.055 --> 00:06:51.014
- now that are reshaping pharmacy, probably the biggest

182
00:06:51.014 --> 00:06:53.334
- amount of change that I've seen in my

183
00:06:53.334 --> 00:06:54.314
- entire career.

184
00:06:55.175 --> 00:06:57.574
- And the the the themes that I'm seeing

185
00:06:57.574 --> 00:06:59.595
- come up are around transparency,

186
00:07:00.750 --> 00:07:02.930
- around competition like we just talked about,

187
00:07:03.470 --> 00:07:05.490
- and a growing expectation,

188
00:07:06.029 --> 00:07:08.370
- especially as our spend is increasing,

189
00:07:08.990 --> 00:07:10.770
- that we demonstrate value.

190
00:07:11.629 --> 00:07:13.170
- So first, just around transparency.

191
00:07:14.785 --> 00:07:17.764
- Employers and patients, they're asking a pretty reasonable

192
00:07:17.824 --> 00:07:20.805
- question, which is how how do the economics

193
00:07:20.944 --> 00:07:23.125
- work for what we're paying for?

194
00:07:23.904 --> 00:07:25.925
- What is the value that's coming back?

195
00:07:26.550 --> 00:07:27.529
- And, it's,

196
00:07:27.910 --> 00:07:30.069
- you know, it's... It can be confusing at

197
00:07:30.069 --> 00:07:32.790
- times when you have the same drug and

198
00:07:32.790 --> 00:07:35.430
- the same patient, and depending on where you

199
00:07:35.430 --> 00:07:37.669
- go to fill the medication, the price is

200
00:07:37.669 --> 00:07:38.169
- different.

201
00:07:39.205 --> 00:07:41.605
- So not a lot of transparency around how

202
00:07:41.605 --> 00:07:43.305
- all of this works with,

203
00:07:44.085 --> 00:07:45.465
- with the with the product.

204
00:07:46.004 --> 00:07:48.485
- The second is around competition. So we saw

205
00:07:48.485 --> 00:07:49.225
- that biosimilars

206
00:07:49.605 --> 00:07:53.069
- and generics, they're creating lots of opportunity for

207
00:07:53.069 --> 00:07:54.210
- savings and affordability.

208
00:07:54.990 --> 00:07:56.770
- But just like I mentioned before,

209
00:07:57.230 --> 00:07:59.970
- because we have a lower cost treatment alternative

210
00:08:00.030 --> 00:08:00.530
- available,

211
00:08:01.310 --> 00:08:03.889
- it doesn't mean that our system is optimized

212
00:08:04.110 --> 00:08:06.314
- or designed to use it. So while we

213
00:08:06.314 --> 00:08:08.414
- have competition creating opportunity,

214
00:08:08.875 --> 00:08:10.574
- unless we change the incentives

215
00:08:10.875 --> 00:08:13.294
- with every part of the supply chain,

216
00:08:13.675 --> 00:08:15.834
- it's going to be very difficult to capture

217
00:08:15.834 --> 00:08:16.974
- its full value.

218
00:08:17.754 --> 00:08:19.615
- Just around competition and transparency,

219
00:08:20.100 --> 00:08:21.939
- we're also seeing a lot of mid market

220
00:08:21.939 --> 00:08:25.699
- PBMs and alternative pricing models challenge the traditional

221
00:08:25.699 --> 00:08:26.759
- pricing and reimbursement.

222
00:08:27.459 --> 00:08:29.399
- And I think that's actually really healthy,

223
00:08:30.020 --> 00:08:32.740
- because just changing the players without changing the

224
00:08:32.740 --> 00:08:34.440
- incentives is not transformation.

225
00:08:35.394 --> 00:08:37.794
- And the third is value. And we can't

226
00:08:37.794 --> 00:08:40.674
- leave a pharmacy conversation without talking about the

227
00:08:40.674 --> 00:08:43.154
- GLP ones and all of the new cellular

228
00:08:43.154 --> 00:08:44.914
- and gene therapies that are coming in the

229
00:08:44.914 --> 00:08:45.414
- pipeline.

230
00:08:45.954 --> 00:08:48.434
- And we have these just remarkable innovations that

231
00:08:48.434 --> 00:08:51.529
- are coming, and they have tremendous clinical benefits.

232
00:08:52.070 --> 00:08:54.549
- And we are looking to balance that with

233
00:08:54.549 --> 00:08:55.049
- affordability

234
00:08:55.429 --> 00:08:57.750
- and appropriate use. And I think this is

235
00:08:57.750 --> 00:09:01.049
- where health plans play an increasingly important role

236
00:09:01.315 --> 00:09:04.695
- of translating that clinical evidence in in partnership

237
00:09:04.754 --> 00:09:06.295
- with health systems and providers

238
00:09:06.835 --> 00:09:08.935
- into thoughtful coverage decisions.

239
00:09:09.475 --> 00:09:11.634
- Because the goal is not just to spend

240
00:09:11.634 --> 00:09:12.615
- less on medications,

241
00:09:13.235 --> 00:09:15.634
- we actually wanna get more health from every

242
00:09:15.634 --> 00:09:16.855
- dollar that we spend.

243
00:09:17.699 --> 00:09:19.779
- Absolutely. And I wonder, Haley, if you could

244
00:09:19.779 --> 00:09:21.240
- also speak to

245
00:09:21.620 --> 00:09:25.320
- broader affordability challenges and policy changes in California

246
00:09:25.539 --> 00:09:26.039
- specifically

247
00:09:26.740 --> 00:09:29.799
- and how that's changing your approach to prescription

248
00:09:29.860 --> 00:09:30.679
- drug access.

249
00:09:31.365 --> 00:09:33.285
- You mentioned GLP ones, and we've obviously seen

250
00:09:33.285 --> 00:09:35.605
- a lot this year, at the federal level

251
00:09:35.605 --> 00:09:38.884
- trying to get GLP ones more affordable for

252
00:09:38.884 --> 00:09:41.044
- the Medicare population. So I wonder if you

253
00:09:41.044 --> 00:09:43.625
- could talk to the California version of that,

254
00:09:44.004 --> 00:09:44.985
- policy changes,

255
00:09:46.100 --> 00:09:48.580
- recently in the state or or, that you're

256
00:09:48.580 --> 00:09:51.299
- keeping an eye on that are shaping your

257
00:09:51.299 --> 00:09:53.240
- approach to prescription drug access.

258
00:09:54.019 --> 00:09:55.940
- Yeah. And I'm so glad you brought up

259
00:09:55.940 --> 00:09:58.100
- the policies that have been changing both at

260
00:09:58.100 --> 00:09:59.940
- the federal level and then, of course, in

261
00:09:59.940 --> 00:10:00.440
- California.

262
00:10:01.394 --> 00:10:04.435
- And again, just a big recognition that it's

263
00:10:04.435 --> 00:10:06.295
- not just about lowering drug prices.

264
00:10:07.154 --> 00:10:09.394
- It's about making sure that the economics of

265
00:10:09.394 --> 00:10:11.975
- pharmacy actually work for employers and members.

266
00:10:12.835 --> 00:10:15.415
- So there have been a number of federal

267
00:10:15.475 --> 00:10:17.399
- reform bills that have gone through.

268
00:10:17.860 --> 00:10:18.759
- And in California,

269
00:10:19.220 --> 00:10:21.139
- one in particular that I would want to

270
00:10:21.139 --> 00:10:23.320
- highlight is SB ten ninety four,

271
00:10:24.019 --> 00:10:26.279
- where the focus is increasingly on transparency,

272
00:10:26.659 --> 00:10:27.159
- accountability,

273
00:10:27.940 --> 00:10:30.259
- and removing the barriers that we have to

274
00:10:30.259 --> 00:10:31.480
- low cost medications.

275
00:10:32.205 --> 00:10:35.024
- And this is particularly relevant for biosimilars

276
00:10:35.485 --> 00:10:38.144
- where it addresses formulary access,

277
00:10:38.684 --> 00:10:39.745
- pharmacist substitution,

278
00:10:40.684 --> 00:10:44.125
- and then certain financial arrangements that can influence

279
00:10:44.125 --> 00:10:46.144
- which products the patients receive.

280
00:10:47.179 --> 00:10:49.899
- Because we've seen firsthand how rebate structures can

281
00:10:49.899 --> 00:10:53.580
- dis... Did they discourage biosimilar adoption even when

282
00:10:53.580 --> 00:10:55.519
- lower cost alternatives are available?

283
00:10:56.299 --> 00:10:57.840
- We believe this bill,

284
00:10:58.460 --> 00:10:59.279
- will markedly

285
00:10:59.820 --> 00:11:00.320
- transform

286
00:11:00.815 --> 00:11:04.355
- the ability to convert patients to clinically equivalent,

287
00:11:04.975 --> 00:11:06.274
- biosimilar medications.

288
00:11:07.134 --> 00:11:09.615
- So we're excited about the new policies that

289
00:11:09.615 --> 00:11:10.674
- are coming through.

290
00:11:11.134 --> 00:11:12.990
- We know that we still have to protect

291
00:11:13.230 --> 00:11:15.629
- continuity of care because not every patient can

292
00:11:15.629 --> 00:11:17.950
- or should be switched simply because a less

293
00:11:17.950 --> 00:11:19.330
- expensive option exists.

294
00:11:19.950 --> 00:11:22.110
- And, I also believe we can't wait for

295
00:11:22.110 --> 00:11:23.649
- legislation to solve everything.

296
00:11:24.190 --> 00:11:26.049
- So through pharmacy care reimagined

297
00:11:26.429 --> 00:11:28.894
- and tools like price check myRx,

298
00:11:29.754 --> 00:11:32.975
- we're taking everyday practical steps to improve transparency

299
00:11:33.034 --> 00:11:34.735
- and affordability for our members.

300
00:11:35.195 --> 00:11:38.394
- So excited about, SB ten ninety four, the

301
00:11:38.394 --> 00:11:40.894
- ability to convert to biosimilars

302
00:11:41.274 --> 00:11:43.559
- more easily and really bring that value back

303
00:11:43.559 --> 00:11:45.419
- to patients and our employers.

304
00:11:46.279 --> 00:11:49.100
- So, Haley, you're now just around six months,

305
00:11:49.559 --> 00:11:52.299
- in your role as chief pharmacy officer. And,

306
00:11:53.240 --> 00:11:55.639
- reflecting back on on your career experience coming

307
00:11:55.639 --> 00:11:57.879
- from some of the largest pharmacy organizations in

308
00:11:57.879 --> 00:12:00.024
- the country, some of the most high quality

309
00:12:00.325 --> 00:12:02.504
- integrated medical systems in the country.

310
00:12:03.125 --> 00:12:05.285
- What are your top priorities at Blue Shield

311
00:12:05.285 --> 00:12:07.144
- of California for the year ahead?

312
00:12:07.924 --> 00:12:10.485
- Yeah. I love this question because it helps

313
00:12:10.485 --> 00:12:12.745
- to ground us on what is most important.

314
00:12:13.669 --> 00:12:15.769
- And for me, people always come first.

315
00:12:16.470 --> 00:12:18.730
- We, of course, need to deliver on performance.

316
00:12:19.190 --> 00:12:21.750
- And the third for for Blue Shield of

317
00:12:21.750 --> 00:12:23.829
- California right now is to ensure that we're

318
00:12:23.829 --> 00:12:25.450
- elevating pharmacy care.

319
00:12:25.934 --> 00:12:27.695
- When I think about people, this is not

320
00:12:27.695 --> 00:12:28.835
- just about the teams

321
00:12:29.375 --> 00:12:32.014
- that are just working so hard to bring,

322
00:12:32.495 --> 00:12:34.415
- a health plan that is worthy of our

323
00:12:34.415 --> 00:12:35.875
- family friends to our members.

324
00:12:36.254 --> 00:12:38.340
- But it's also the members that we serve.

325
00:12:38.820 --> 00:12:41.220
- I wanna build a culture where every decision

326
00:12:41.220 --> 00:12:43.620
- starts with a member. That means empowering our

327
00:12:43.620 --> 00:12:46.040
- teams to think beyond their individual functions

328
00:12:46.660 --> 00:12:49.379
- and just really ask, how how does what

329
00:12:49.379 --> 00:12:51.300
- I'm doing today make health care better for

330
00:12:51.300 --> 00:12:52.680
- the people that we serve?

331
00:12:53.455 --> 00:12:55.134
- As a not for profit health plan at

332
00:12:55.134 --> 00:12:56.195
- Blue Shield of California,

333
00:12:56.654 --> 00:12:58.174
- I think I mentioned our mission is to

334
00:12:58.174 --> 00:13:00.254
- make health care worthy of our family and

335
00:13:00.254 --> 00:13:02.115
- friends and sustainably affordable.

336
00:13:02.654 --> 00:13:04.414
- And we've seen this come through in our

337
00:13:04.414 --> 00:13:07.450
- engagement surveys that this truly is something that

338
00:13:07.450 --> 00:13:09.550
- is in the heart of our team members,

339
00:13:10.170 --> 00:13:11.629
- and how they work every day.

340
00:13:12.170 --> 00:13:14.910
- The second is around execution. We've made tremendous

341
00:13:14.970 --> 00:13:18.009
- progress with our pharmacy care reimagine model, but

342
00:13:18.009 --> 00:13:20.170
- we also know that launching the model is

343
00:13:20.170 --> 00:13:21.070
- just the beginning.

344
00:13:21.695 --> 00:13:23.855
- So we have these changes that we've made

345
00:13:23.855 --> 00:13:25.634
- and we've gained a lot of flexibility.

346
00:13:26.654 --> 00:13:28.654
- Now we have to deliver on that promise,

347
00:13:28.975 --> 00:13:29.794
- of affordability,

348
00:13:30.254 --> 00:13:32.914
- reliability, and a seamless member experience.

349
00:13:33.950 --> 00:13:35.629
- I always say that, you know, members, they

350
00:13:35.629 --> 00:13:38.670
- don't experience our strategy. They experience whether their

351
00:13:38.670 --> 00:13:40.049
- pharmacy care works.

352
00:13:40.910 --> 00:13:43.549
- The third is the elevating pharmacy care. And

353
00:13:43.549 --> 00:13:45.730
- when I think about the practice of pharmacy,

354
00:13:45.790 --> 00:13:47.090
- the profession of pharmacy,

355
00:13:47.884 --> 00:13:50.764
- we know that, if you can connect clinical

356
00:13:50.764 --> 00:13:52.065
- pharmacy with members

357
00:13:52.445 --> 00:13:55.085
- and they are taking their medications appropriately, they

358
00:13:55.085 --> 00:13:57.404
- have an avenue to ask questions, that their

359
00:13:57.404 --> 00:13:58.945
- doses are getting titrated,

360
00:13:59.725 --> 00:14:01.404
- all of that is going to lead to

361
00:14:01.404 --> 00:14:02.625
- better care delivery.

362
00:14:03.360 --> 00:14:05.600
- And at Blue Shield of California, we're thinking

363
00:14:05.600 --> 00:14:07.620
- about how do we do that through innovative

364
00:14:07.840 --> 00:14:08.340
- partnerships.

365
00:14:09.360 --> 00:14:11.919
- I've also seen firsthand the power of aligning

366
00:14:11.919 --> 00:14:13.860
- clinical care and financial incentives

367
00:14:14.480 --> 00:14:17.059
- through an integrated care and coverage,

368
00:14:17.840 --> 00:14:18.340
- model.

369
00:14:18.764 --> 00:14:21.504
- And I believe we can bring that to

370
00:14:21.644 --> 00:14:24.125
- more people. I ultimately want us to be

371
00:14:24.125 --> 00:14:26.945
- known for manage... Not just for managing pharmacy

372
00:14:27.004 --> 00:14:27.504
- costs,

373
00:14:27.805 --> 00:14:29.884
- but for making health care better for our

374
00:14:29.884 --> 00:14:30.384
- members.

375
00:14:31.320 --> 00:14:33.240
- Certainly. And I think it's a really great

376
00:14:33.240 --> 00:14:35.000
- line that your members might not know the

377
00:14:35.000 --> 00:14:37.000
- business strategy behind it all, but they certainly

378
00:14:37.000 --> 00:14:37.500
- know,

379
00:14:37.960 --> 00:14:38.940
- what they experience

380
00:14:39.399 --> 00:14:42.220
- at the pharmacy counter. So I I think

381
00:14:42.360 --> 00:14:44.519
- where I wanna leave things, Haley, is having

382
00:14:44.519 --> 00:14:47.664
- you offer any final bits of advice or

383
00:14:47.664 --> 00:14:48.485
- final thoughts

384
00:14:49.184 --> 00:14:51.584
- to your pharmacy colleagues around the country who

385
00:14:51.584 --> 00:14:53.985
- are facing very similar challenges, if not the

386
00:14:53.985 --> 00:14:55.764
- same challenges all over the country.

387
00:14:56.065 --> 00:14:57.764
- And what you you would say to them,

388
00:14:58.144 --> 00:15:00.659
- as they also work to make prescription drugs

389
00:15:03.220 --> 00:15:05.399
- accessible to their members? Yeah. If

390
00:15:06.179 --> 00:15:09.100
- there's one thing I've learned over the years,

391
00:15:09.139 --> 00:15:11.539
- it's that health care has no shortage of

392
00:15:11.539 --> 00:15:15.159
- just brilliant people with great intentions and innovative

393
00:15:15.379 --> 00:15:15.779
- ideas.

394
00:15:16.745 --> 00:15:18.904
- We see that come through with manufacturers who

395
00:15:18.904 --> 00:15:20.845
- are developing remarkable therapies,

396
00:15:21.465 --> 00:15:21.965
- providers

397
00:15:22.345 --> 00:15:24.205
- who wanna deliver great care,

398
00:15:24.664 --> 00:15:27.544
- and health plans who wanna keep health care

399
00:15:27.544 --> 00:15:28.044
- affordable.

400
00:15:28.990 --> 00:15:31.870
- So my advice is to think beyond the

401
00:15:31.870 --> 00:15:32.370
- boundaries

402
00:15:32.750 --> 00:15:34.210
- of your own organization.

403
00:15:35.070 --> 00:15:36.610
- Start with the patient outcome

404
00:15:36.990 --> 00:15:39.009
- that you're trying to achieve and work backward.

405
00:15:39.149 --> 00:15:40.210
- Challenge the incentives

406
00:15:40.830 --> 00:15:43.105
- that may not be working for the entire

407
00:15:43.105 --> 00:15:45.605
- system and be willing to partner differently.

408
00:15:46.465 --> 00:15:49.205
- The goal isn't to prove our original idea

409
00:15:49.264 --> 00:15:51.924
- is right. It's to get the outcome right.

410
00:15:52.225 --> 00:15:54.865
- Because ultimately, our success should be measured not

411
00:15:54.865 --> 00:15:56.804
- just by what by what we save,

412
00:15:57.105 --> 00:15:58.759
- but but it's the health and the value

413
00:15:58.759 --> 00:16:00.919
- that we create for the people that we

414
00:16:00.919 --> 00:16:01.419
- serve.

415
00:16:01.879 --> 00:16:04.620
- I'm super excited again to be in pharmacy.

416
00:16:04.679 --> 00:16:06.059
- This is a great time

417
00:16:06.519 --> 00:16:09.419
- when we can redesign the health care system

418
00:16:10.014 --> 00:16:12.834
- to really deliver on the promise of care

419
00:16:12.894 --> 00:16:13.954
- and compassion,

420
00:16:14.975 --> 00:16:18.195
- for every member and every human out there,

421
00:16:18.894 --> 00:16:20.914
- that really needs the support,

422
00:16:21.980 --> 00:16:24.059
- during what can be some of the toughest

423
00:16:24.059 --> 00:16:26.540
- times in in their life for themselves or

424
00:16:26.540 --> 00:16:28.000
- for the families and friends,

425
00:16:28.620 --> 00:16:29.759
- that surround them.

426
00:16:30.540 --> 00:16:33.019
- Wonderful. Well, Haley, I cannot thank you enough

427
00:16:33.019 --> 00:16:34.779
- for taking the time to chat with us

428
00:16:34.779 --> 00:16:37.644
- and for sharing your expertise with our listeners.

429
00:16:37.644 --> 00:16:39.345
- We really appreciate you doing so.

430
00:16:39.884 --> 00:16:41.725
- Thank you so much, Jacob, for having me

431
00:16:41.725 --> 00:16:42.225
- today.

432
00:16:42.605 --> 00:16:45.085
- Yeah. Anytime. And to our listeners, if you'd

433
00:16:45.085 --> 00:16:47.325
- like to listen to more podcasts from Becker's

434
00:16:47.325 --> 00:16:50.544
- Healthcare, you can visit beckershospitalreview.com.